APA (7th ed.) Citation

S, G., E, F., K, T., P, K., T, F., E, S., . . . ML, S. (2025). Endotheliopathy syndromes, TA-TMA, and SOS, are risk factors for morbidity and mortality in critically ill pediatric hematopoietic cell transplant recipients. Frontiers in oncology, 15, 1642939. https://doi.org/10.3389/fonc.2025.1642939

Chicago Style (17th ed.) Citation

S, Goel, et al. "Endotheliopathy Syndromes, TA-TMA, and SOS, Are Risk Factors for Morbidity and Mortality in Critically Ill Pediatric Hematopoietic Cell Transplant Recipients." Frontiers in Oncology 15 (2025): 1642939. https://doi.org/10.3389/fonc.2025.1642939.

MLA (9th ed.) Citation

S, Goel, et al. "Endotheliopathy Syndromes, TA-TMA, and SOS, Are Risk Factors for Morbidity and Mortality in Critically Ill Pediatric Hematopoietic Cell Transplant Recipients." Frontiers in Oncology, vol. 15, 2025, p. 1642939, https://doi.org/10.3389/fonc.2025.1642939.